TRIB1 has been implicated in a number of human malignancies including acute myeloid leukemia (AML), non-small cell lung carcinoma (NSCLC), prostate cancer, hepatocellular carcinoma (HCC) and colorectal cancer (CRC)20–24. This evidence concerns the gene TRIB1 and Familial prostate cancer.